Nxera Pharma Co Ltd (SOLTF)
9.30
-0.42
(-4.32%)
USD |
OTCM |
Apr 26, 13:35
Nxera Pharma Gross Profit (Quarterly): 37.53M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 37.53M |
September 30, 2023 | 15.24M |
June 30, 2023 | 7.798M |
March 31, 2023 | 6.443M |
December 31, 2022 | 47.82M |
September 30, 2022 | 43.25M |
June 30, 2022 | 8.451M |
March 31, 2022 | 7.153M |
December 31, 2021 | 121.63M |
September 30, 2021 | 2.508M |
June 30, 2021 | 15.49M |
March 31, 2021 | 9.263M |
December 31, 2020 | 39.92M |
September 30, 2020 | 16.29M |
June 30, 2020 | 11.11M |
March 31, 2020 | 9.063M |
December 31, 2019 | 15.73M |
September 30, 2019 | 23.33M |
June 30, 2019 | 15.83M |
March 31, 2019 | 26.54M |
December 31, 2018 | 6.511M |
September 30, 2018 | 8.694M |
June 30, 2018 | 7.656M |
March 31, 2018 | 6.255M |
December 31, 2017 | 8.527M |
Date | Value |
---|---|
September 30, 2017 | 22.80M |
June 30, 2017 | 25.06M |
March 31, 2017 | 15.68M |
December 31, 2016 | 11.72M |
September 30, 2016 | 7.386M |
June 30, 2016 | 139.64M |
March 31, 2016 | 3.524M |
December 31, 2015 | 42.81M |
September 30, 2015 | 16.08M |
June 30, 2015 | 4.740M |
March 31, 2015 | 22.64M |
December 31, 2014 | 3.366M |
September 30, 2014 | 2.944M |
June 30, 2014 | 2.085M |
March 31, 2014 | 1.603M |
December 31, 2013 | 2.349M |
September 30, 2013 | 14.02M |
June 30, 2013 | 0.3164M |
March 31, 2013 | 0.6239M |
December 31, 2012 | 6.232M |
September 30, 2012 | 12.61M |
June 30, 2012 | 0.9751M |
March 31, 2012 | 0.0157M |
December 31, 2011 | -0.0351M |
September 30, 2011 | 6.078M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
2.508M
Minimum
Sep 2021
121.63M
Maximum
Dec 2021
23.89M
Average
15.49M
Median
Jun 2021
Gross Profit (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 4.956B |
PeptiDream Inc | 20.24M |
Stemcell Holdings Inc | 2.657M |
Healios KK | 0.0474M |
AnGes Inc | 0.049M |